Aug 25, 2026 04:14AM
Aug 6, 2026 04:17PM
Aug 6, 2026 07:24AM
Jul 16, 2026 02:21AM
Jun 16, 2026 06:37AM
Jun 15, 2026 06:48AM
Jun 15, 2026 05:41AM Intellia Therapeutics (NTLA) Reiterated at Market Outperform by Citizens
May 13, 2026 07:50AM
May 12, 2026 09:58AM
May 11, 2026 07:54AM
Apr 29, 2026 04:12PM
Apr 28, 2026 04:11AM
Apr 27, 2026 02:50PM
Apr 27, 2026 01:10PM Intellia Therapeutics (NTLA) PT Raised to $35 at Leerink Partners
Apr 27, 2026 11:34AM
Apr 27, 2026 10:48AM
Apr 27, 2026 10:10AM
Apr 27, 2026 07:03AM
Mar 4, 2026 06:01AM
Mar 3, 2026 09:54AM
Mar 3, 2026 07:30AM Intellia presents longer-term data for hereditary angioedema treatment
Mar 3, 2026 04:56AM
Mar 2, 2026 03:25PM
Mar 2, 2026 02:48PM
Mar 2, 2026 02:18PM
Mar 2, 2026 02:04PM
Mar 2, 2026 12:28PM
Mar 2, 2026 12:05PM William Blair Upgrades Intellia Therapeutics (NTLA) to Outperform
Mar 2, 2026 10:25AM
Mar 2, 2026 10:04AM
Feb 26, 2026 01:31PM
Feb 26, 2026 01:28PM
Feb 26, 2026 07:35AM
Jan 28, 2026 06:39AM
Jan 27, 2026 11:29AM Intellia Therapeutics (NTLA) PT Raised to $7 at Baird
Dec 19, 2025 09:06AM
Nov 11, 2025 04:31PM
Nov 11, 2025 07:17AM
Nov 11, 2025 03:20AM
Nov 7, 2025 08:56AM
Nov 7, 2025 04:48AM
Nov 7, 2025 03:50AM JPMorgan Downgrades Intellia Therapeutics (NTLA) to Underweight
Nov 6, 2025 04:29PM
Oct 31, 2025 09:54AM
Oct 31, 2025 07:27AM
Oct 30, 2025 04:55AM
Oct 29, 2025 04:24PM
Oct 28, 2025 06:41AM
Oct 28, 2025 06:26AM Canaccord Genuity Reiterates Buy Rating on Intellia Therapeutics (NTLA)
Oct 28, 2025 04:23AM

443,976 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All